RK
Roger Kitterman
OtherActiveManaging Partner at Mass General Brigham Ventures
27
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Roger Kitterman.
Investment Thesis & Strategy
Roger Kitterman, as Managing Partner at Mass General Brigham Ventures, invests in various stages of biotech companies, leveraging the resources and expertise of Mass General Brigham to support innovation in the healthcare sector.
Investment Activity
Deals per year over the last 4 years
5
20183
20192
20202
2021Portfolio Companies
Selected investments from their portfolio of 27 companies
I
InStore Finance
Fintech · Seed, 2021
I
ImmuneXcite
Biotech · Seed, 2021
Z
ZielBio
Biotech · Seed, 2020
Q
QPID Health
Healthcare · Seed, 2020
P
Pykus Therapeutics
Biotech · Seed, 2019
A
Affinia Therapeutics
Biotech · Seed, 2019
S
SwanBio Therapeutics
Biotech · Seed, 2019
T
Triplet Therapeutics
Biotech · Seed, 2018
A
Alizé Pharma
Biotech · Seed, 2018
N
Nocion Therapeutics
Biotech · Seed, 2018
T
TargAnox
Biotech · Seed, 2018
R
ROME Therapeutics
Biotech · Seed, 2018
Frequently Asked Questions
Roger Kitterman focuses on Seed stage investments.
Related Investors
Shawn Broderick
Massachusetts, United States · 120 deals
Rich Levandov
Massachusetts, United States · 61 deals
Mike Troiano
Massachusetts, United States · 19 deals
David Orfao
Massachusetts, United States · 9 deals
Mark Roberge
Massachusetts, United States · 3 deals
Robert Weisskoff
Massachusetts, United States · 3 deals